Access published abstracts from the 66th Annual Scientific Meeting via the journal Headache® here.

Abstract Frequently Asked Questions

Do I need to indicate that my abstract has been submitted to other meetings/journals (“Encores”)?
Yes. You can submit an abstract that has previously been presented/submitted within the last year as long as it is the same data and information. We ask that any “Encore” presentations/submissions are identified when/where they were previously submitted. 

Are there word counts or formatting requirements?
No. Your abstract is not limited to a word count. We ask each abstract have a One Sentence Summary, Background, Methods, Results, and Conclusion sections. You can include/upload up to two (2) images and diagrams to support your work.

What if my abstract doesn’t have data or is a planned study? 
We do not accept abstracts with no data. We do encourage submissions of data outside of traditional quantitative analysis, including Qualitative data, Methodological analysis, and Systematic reviews. We do not accept protocol registrations or planned studies for which no data are currently available.

Do I need to complete a financial disclosure?
Not yet. Only authors of (non-industry) abstracts chosen for oral presentations must complete a financial disclosure. All submitters will be asked to indicate if they have patient consent when including case-based data.

Do you have an anticipated time for when abstract decisions will be sent out?
Notifications for abstracts will go out on or about March 29, 2024.

Can I get an extension on the abstract submission deadline?
Due to the review process and timeline, extensions are not permitted. 

Is there an abstract submission fee?
No, there is no submission fee. 

Do you accept industry abstracts?
Yes. Industry abstracts need to be identified and are not eligible for CME credits. Abstracts submitted by industry will be considered in separate categories from other abstracts. Industry abstracts fall into two categories:
1) Industry-initiated Clinical Trials
2) Industry-initiated Research Involving Drugs, Devices, or other Products with a Commercial Interest. This category will not include investigator-initiated studies that may have industry support. 

Will abstracts be published? If yes, when and where?
Accepted abstracts will be published in the journal, Headache®. They are typically in the June edition or sent as a supplement to the June edition. 

Is there a limit on how many abstracts an author can submit or present?
No, there is no limit. However AHS does ask that you comply with our Smallest Publishable Unit Policy: The AHS Scientific Meeting guidelines specifically address the parsing of results of a single research study into multiple abstract submissions.

Examples of this approach include: (a) submission of two different abstracts from a single study ‐ one reporting safety data and the other efficacy data ‐ rather than submitting one abstract; and (b) submission of one abstract on efficacy in the entire study cohort, and another abstract on subgroup analyses.

Sometimes identified as the “smallest‐publishable unit” strategy, this strategy runs counter to the high standards of scientific presentation at the AHS Annual meeting. Unless a compelling rationale is provided and each abstract clearly cross‐references other abstract(s) generated from the same study, the AHS reserves the right to exclude or merge your submissions.

What is the embargo policy?
All content and data is embargoed until June 12, 2024 @11:59 pm PT. 

When and where can I view abstracts?
Abstracts will be available in the mobile app and the journal,  Headache®. 

Are there text abstracts available?
Yes, in the journal, Headache®. 

When will AHS abstracts be publicly available?
They are available starting June 13, 2024 @ 12am PT. They will be published in the journal, Headache®, as well as through the meeting’s mobile app. 

How do I register for the meeting?
All accepted abstract lead/presenting authors will receive a special set of instructions with their acceptance notice including information on how to register for the meeting. 

Are lead/presenting authors required to register for the meeting?
If you plan to present at the meeting (either in-person or virtually), you must register for the meeting. 

What if the lead/presenting author cannot attend the meeting?
If this arises, AHS will allow one of the other authors to register and present on their behalf. 

Do poster presenters need to register for the meeting?
Yes, poster presenters must register. 

AHS Policy on Industry-Submitted Abstracts 

Still have questions? Contact us at ahshq@talley.com.